A Phase II Study of Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone (D-ClaPd) In Multiple Myeloma Patients Previously Exposed to Daratumumab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Study of CAR-T Therapy in Older Patients
- Status
- RECRUITING
- Phase
- N/A
The Feasibility and Effects of Exercise on Patients Suffering From Multiple Myeloma
- Status
- SUSPENDED
- Phase
- NA
A Study of BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE1
Carfilzomib, Daratumumab, Lenalidomide and Dexamethasone as First Line Treatment in Multiple Myeloma
- Status
- WITHDRAWN
- Phase
- PHASE3
Study of BiRd Regimen Combined With BCMA CAR T-cell Therapy in Newly Diagnosed Multiple Myeloma (MM) Patients
- Status
- UNKNOWN
- Phase
- PHASE3
Study of Ciforadenant in Combination With Daratumumab in Patients With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Randomized Phase II Study in Elderly Patients With Newly Diagnosed Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE2
A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3602 Capsule
- Status
- UNKNOWN
- Phase
- PHASE1
Bone Pain in Multiple Myeloma- a Translational Study
- Status
- UNKNOWN
- Phase
- N/A
Safety and Efficacy of BCMA-Targeted CAR-T Therapy for Relapsed/Refractory Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Effect of Sleep Quality on Hematopoietic Cell Transplant Patient Outcomes
- Status
- TERMINATED
- Phase
- NA
BCMA-Targeted CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma and Plasma Cell Disease
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Multiple Myeloma and Environmental Exposure to Pesticides in the French West Indies: A Population Based Case-control Study.
- Status
- UNKNOWN
- Phase
- N/A
A Study of Pembrolizumab Added to the Standard First-Line Therapy of Cyclophosphamide, Bortezomib, and Dexamethasone (CyBorD) for NDMM NTE
- Status
- WITHDRAWN
- Phase
- PHASE2
Effects of Early Palliative Care Integration on Patients With Newly Diagnosed Multiple Myeloma
- Status
- COMPLETED
- Phase
- NA
Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Safety and Efficacy Study Evaluating CTX120 in Subjects With Relapsed or Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1
Study of Pomalidomide, Oral Dexamethasone and Very Low-dose Cyclophosphamide in Patients With Refractory Multiple Myeloma Who Have Received Lenalidomide and Bortezomib
- Status
- TERMINATED
- Phase
- PHASE2